KoBioLabs, Inc (KOSDAQ:348150)

South Korea · Delayed Price · Currency is KRW

5,900.00

+200.00 (3.51%)

At close: Jan 28, 2026

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
New Drugs, Probiotics and Health Functional Foods	68.36B	Log In	Log In	Log In	Log In	Upgrade
New Drugs, Probiotics and Health Functional Foods Growth	106.28%	Log In	Log In	Log In	Log In	Upgrade
Technology Transfer	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
South Korea	68.09B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	109.04%	Log In	Log In	Log In	Log In	Upgrade
Overseas	265.25M	Log In	Log In	Log In	Log In	Upgrade
Overseas Growth	-52.99%	Log In	Log In	Log In	Log In	Upgrade